Literature DB >> 4242612

[Orthology and pathology of the Langhans cells of the aortic intima in man].

M Schönfelder.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4242612

Source DB:  PubMed          Journal:  Pathol Microbiol (Basel)        ISSN: 0031-2959


× No keyword cloud information.
  6 in total

1.  Adult human aortic cells in primary culture: heterogeneity in shape.

Authors:  A N Orekhov; A V Krushinsky; E R Andreeva; V S Repin; V N Smirnov
Journal:  Heart Vessels       Date:  1986       Impact factor: 2.037

2.  Three-dimensional cytoarchitecture of normal and atherosclerotic intima of human aorta.

Authors:  M D Rekhter; E R Andreeva; A A Mironov; A N Orekhov
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

3.  Intimal cells and atherosclerosis. Relationship between the number of intimal cells and major manifestations of atherosclerosis in the human aorta.

Authors:  A N Orekhov; E R Andreeva; A V Krushinsky; I D Novikov; V V Tertov; G V Nestaiko; Kh A Khashimov; V S Repin; V N Smirnov
Journal:  Am J Pathol       Date:  1986-11       Impact factor: 4.307

4.  Cellular composition of atherosclerotic and uninvolved human aortic subendothelial intima. Light-microscopic study of dissociated aortic cells.

Authors:  A N Orekhov; I I Karpova; V V Tertov; S A Rudchenko; E R Andreeva; A V Krushinsky; V N Smirnov
Journal:  Am J Pathol       Date:  1984-04       Impact factor: 4.307

5.  Monoclonal antibody reveals heterogeneity in human aortic intima: detection of a ganglioside antigen associated with a subpopulation of intimal cells.

Authors:  A N Orekhov; G F Kalantarov; E R Andreeva; N V Prokazova; I N Trakht; L D Bergelson; V N Smirnov
Journal:  Am J Pathol       Date:  1986-03       Impact factor: 4.307

Review 6.  Development of Antiatherosclerotic Drugs on the basis of Natural Products Using Cell Model Approach.

Authors:  Alexander N Orekhov; Igor A Sobenin; Victor V Revin; Yuri V Bobryshev
Journal:  Oxid Med Cell Longev       Date:  2015-06-09       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.